Smart Nanomaterials and Natural Biologics for Innate-Adaptive Immune Reprogramming: A Nanobiotechnology Framework for...

Area of Science:

• Immunology
• Nanobiotechnology
• Translational Medicine

Background:

• The innate-adaptive immune interface critically influences therapeutic outcomes, yet many immunotherapies fail due to oversimplified views of immunity.
• Current approaches often neglect the complex interplay of tissue context, cell fate, and metabolic states in shaping immune responses.

Purpose of the Study:

• Introduce the immunoscape framework as a nanobiotechnology-oriented model for understanding and controlling the immune interface.
• Provide a design layer for predicting context-dependent immune outcomes in therapeutic interventions.
• Propose translational design rules for clinically realistic immune-reprogramming nanomedicines.

Main Methods:

• Develop a nanobiotechnology-oriented model (immunoscape framework) for immune-state mapping.
• Integrate controllable translational variables such as delivery route, release kinetics, and biomolecular corona identity.
• Analyze natural biologics (e.g., beta-glucans, polyphenols) and smart nanomaterials (e.g., lipid nanoparticles, biomimetic vesicles).

Main Results:

• The immunoscape framework links immune-state mapping with controllable variables for predictable immune outcomes.
• Identified natural biologics and smart nanomaterials as key strategies for reprogramming the immune interface.
• Proposed design rules to guide the development of immune-reprogramming nanomedicines.

Conclusions:

• The immunoscape framework enables a more sophisticated approach to immunotherapy design by considering the complex immune network.
• Reprogramming the innate-adaptive immune interface using natural biologics and nanomaterials holds promise for diverse therapeutic applications.
• Translational design rules are crucial for developing effective nanomedicines for cancer, infectious, inflammatory, and regenerative medicine.